Literature DB >> 7814605

Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines.

H Li1, M W Freeman, P Libby.   

Abstract

Scavenger receptor (ScR)-mediated uptake of modified lipoproteins may contribute to the transformation of smooth muscle cells into lipid-laden foam cells during atherogenesis. This study examined the in vivo expression of ScRs in aortas, with or without balloon injury, taken from hypercholesterolemic or normocholesterolemic rabbits. Numerous intimal cells in the rabbit aortic lesions expressed ScRs as detected by immunocytochemical staining with a goat anti-rabbit ScR antibody. Single immunostaining for cell identification markers in serial sections, as well as double staining, confirmed the expression of ScRs by both intimal smooth muscle cells and macrophages. To explore potential inducers of ScR expression by smooth muscle cells in vivo, we studied the regulation of ScR expression in vitro by cytokines known to be present in atherosclerotic lesions. Tumor necrosis factor-alpha (TNF-alpha) or interferon-gamma (IFN-gamma) increased ScR mRNA levels, protein expression, and AcLDL degradative activity in cultured rabbit aortic smooth muscle cells. The induction of ScR expression in intimal smooth muscle cells in vivo could be a useful marker of smooth muscle cell activation during atherogenesis and may contribute to foam cell formation by this cell type following balloon injury and/or hypercholesterolemia. Cytokines, such as TNF-alpha or IFN-gamma, may stimulate some of the phenotypic changes that characterize the alteration in gene expression of intimal smooth muscle cells in rabbit atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814605      PMCID: PMC295387          DOI: 10.1172/JCI117628

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

Authors:  S L Acton; P E Scherer; H F Lodish; M Krieger
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

2.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions.

Authors:  J Luoma; T Hiltunen; T Särkioja; S K Moestrup; J Gliemann; T Kodama; T Nikkari; S Ylä-Herttuala
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 3.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Complementation of mutations in the LDL pathway of receptor-mediated endocytosis by cocultivation of LDL receptor-defective hamster cell mutants.

Authors:  M Krieger
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

5.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions.

Authors:  R G Gerrity
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307

6.  Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins.

Authors:  R E Pitas; T L Innerarity; R W Mahley
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

7.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages.

Authors:  M S Brown; S K Basu; J R Falck; Y K Ho; J L Goldstein
Journal:  J Supramol Struct       Date:  1980

8.  Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.

Authors:  H Tanaka; G K Sukhova; S J Swanson; S K Clinton; P Ganz; M I Cybulsky; P Libby
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

9.  Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages.

Authors:  A M Fogelman; M E Haberland; J Seager; M Hokom; P A Edwards
Journal:  J Lipid Res       Date:  1981-09       Impact factor: 5.922

10.  Culture of quiescent arterial smooth muscle cells in a defined serum-free medium.

Authors:  P Libby; K V O'Brien
Journal:  J Cell Physiol       Date:  1983-05       Impact factor: 6.384

View more
  31 in total

1.  Histological changes and risk factor associations in type 2 atherosclerotic lesions (fatty streaks) in young adults.

Authors:  Satoki Homma; Dana A Troxclair; Arthur W Zieske; Gray T Malcom; Jack P Strong
Journal:  Atherosclerosis       Date:  2011-07-21       Impact factor: 5.162

2.  Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs.

Authors:  A W Stitt; C He; S Friedman; L Scher; P Rossi; L Ong; H Founds; Y M Li; R Bucala; H Vlassara
Journal:  Mol Med       Date:  1997-09       Impact factor: 6.354

3.  Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.

Authors:  Jinwei Tian; Sining Hu; Xue Han; Nana Dong; Huai Yu; Yanli Sun; Bo Yu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

4.  Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells.

Authors:  Y F Zhou; E Guetta; Z X Yu; T Finkel; S E Epstein
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 5.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 6.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

7.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.

Authors:  S Gupta; A M Pablo; X c Jiang; N Wang; A R Tall; C Schindler
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

8.  Mechanism of Enhanced Cellular Uptake and Cytosolic Retention of MK2 Inhibitory Peptide Nano-polyplexes.

Authors:  Kameron V Kilchrist; Brian C Evans; Colleen M Brophy; Craig L Duvall
Journal:  Cell Mol Bioeng       Date:  2016-06-06       Impact factor: 2.321

9.  Increased interleukin-1alpha and interleukin-1beta production by macrophages of low-density lipoprotein receptor knock-out mice stimulated with lipopolysaccharide is CD11c/CD18-receptor mediated.

Authors:  M G Netea; P N Demacker; B J Kullberg; O C Boerman; I Verschueren; A F Stalenhoef; J W Van Der Meer
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 10.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis.

Authors:  Amanda C Doran; Nahum Meller; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.